Navigation Links
Diamyd(R) Study Published in Prestigious New England Journal of Medicine
Date:10/9/2008

results are considered to be of such quality and clinical value strengthens our position in the medical and industrial worlds," says Elisabeth Lindner, president and CEO of Diamyd. "We are now moving forward preparing the market introduction of Diamyd(R)."

About the article:

"GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes"

J Ludvigsson et al., N Engl J Med 2008;359 (Epub ahead of print 10.1056/NEJMoa0804328)

About Diamyd(R) Type 1:

Diamyd(R) Type 1 is the treatment of recently diagnosed patients with the Diamyd(R) diabetes vaccine. Diamyd(R) Type 1 is a simple treatment without any serious side effects. This treatment is now being tested in Phase III studies in Europe and the US. The company plans to complete the application for market approval in late 2010. The annual market for Diamyd(R) Type 1 is estimated at about one billion dollars.

About the mechanism of action:

Type 1 diabetes is an autoimmune disease in which the body's own immune system attacks the cells in the body that produce insulin. The active ingredient in Diamyd(R) is glutamic acid decarboxylase (GAD), which is a dominant antigen in type 1 diabetes. By treating with GAD formulated as a vaccine, the patient's immune system is affected in such a way that it down regulates the attack on the insulin-producing cells. Stopping this autoimmune process is the cornerstone in curing type 1 diabetes.

Immunological analyses from the Phase II study as presented in the New England Journal of Medicine help to form an understanding of the Diamyd(R) vaccine's mechanism of action. A significant increase in regulatory T-cell activity was seen, which is considered decisive in counteracting the course of autoimmune diseases.

About the Phase II study:

The Phase II study now being presented comprised 70 patients aged 10-18 with type 1 diabetes. The patients, who received two injections of Diamyd(R), retained their own ability to pro
'/>"/>

SOURCE Diamyd Medical AB (publ)
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
2. Wild Blueberries Take Top Spot in New Antioxidant Research Study
3. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
4. Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period
5. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
6. Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
7. New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohns Disease According to First-of-its Kind Study
8. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
9. Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
10. The Childrens Hospital of Philadelphia Announces New Regional Participant in The National Childrens Study
11. Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., HOUSTON, Nov. 6 C...hat the company will report financial results for ...iscal year ending April 30, 2010 on Wednesday, Nov...onduct a conference call to discuss those results ..., Fiscal Year 2010 Second Quarter Results Confe...
(Date:11/6/2009)..., SAN DIEGO, Nov. 6 Californi...er 9, 2009 as "No Drugs Down the Drain" week for i...onal campaign sponsored by public and private agen...harmaceutical pollution in our source water suppli...unty customers are encouraged to drop off expired ...
(Date:11/5/2009)..., POINT RICHMOND, Calif., Nov. 5 /PRNewswire-...daq: TSPT ), a specialty pharmaceutical company f... proprietary products that address important thera...nnounced it will host a webcast and teleconference...ancial results on Thursday, November 12, 2009, at ...
Breaking Medicine Technology:Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2National Autism Center Releases Groundbreaking Report on Autism Treatments 57915 1National Autism Center Releases Groundbreaking Report on Autism Treatments 57915 2National Autism Center Releases Groundbreaking Report on Autism Treatments 57915 3Yoga Sandals 28R 29 Footwear Steps up with Donations for Womens Health 57913 1Yoga Sandals 28R 29 Footwear Steps up with Donations for Womens Health 57913 2Gerresheimer Expands in the Global Pharmaceutical Plastic Business 57912 1Gerresheimer Expands in the Global Pharmaceutical Plastic Business 57912 2Gerresheimer Expands in the Global Pharmaceutical Plastic Business 57912 3
(Date:11/8/2009)... Passage of H.R. 3961 to Secure the Stability of M...ire/ -- Statement Attributable to: J. James Rohack..., (Logo: http://www.newscom.com/cgi-bin/prnh/...age of the House health reform bill, which will he...icians and calls for swift passage of H.R. 3961 to...
(Date:11/8/2009)...e Shows Who Sides With Working Families vs. Insura...wswire-USNewswire/ -- On the heels of an historic ...r a good, balanced health care reform bill, the Pe... state,s U.S. representatives voted on HR 3962, th...he legislation, which passed Saturday evening by a...
(Date:11/7/2009)... 7 Karen Ignagni, Presi...AHIP), released the following statement today on H...ongly support comprehensive health care reform, an...ing a complete overhaul of how health insurance is...ed coverage, elimination of pre-existing condition...
(Date:11/7/2009)... The American Medical As...ctor of Health at the Family Violence Prevention F...oday at its semi-annual policy-making meeting. Th...t honor the AMA House of Delegates bestows on a no...com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ms. J...
(Date:11/7/2009)... Members of the AMA are ...ncy resolution rescinding the AMA,s support of HR ...ey are responsible to their PATIENTS, not the lead...of Policy for the Association of American Physicia...on of other medical groups. ,, "If the AMA lea...
Breaking Medicine News(10 mins):Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Family Violence Prevention Expert 2
...e "Extremely Affordable Health Innovations" Poste...al World Health Care Congress with support from Gr...ive organizations involved in developing or implem...eloped, or are in the process of developing, to th...
...EIGH, N.C., March 13 North Carolina students inte...re encouraged to attend the 2009 Optometry Career ...th Carolina and the N.C. State Education Assistanc...0:00 a.m. - 12:00 noon, Tuesday, March 24, 2009 in...
...CSF Medical Center has received a $125 million gif...specialty and cancer hospital complex at the UCSF ...his is the largest support to date for the $600 mi...t from other philanthropists, was made by Charles ...
...hanging physician behaviors forecast print news de... FALLS, N.J., March 13 , , Background : The...nsizing of many U.S. newspapers just a day after ...rk Times reports that three papers are ceasing t...
... HARBIN, China, March 13 /PRNewswire-Asia/ -- Chin...r "the Company") (Nasdaq: CSKI ), a leading full...-the-counter drugs in the,People,s Republic of Chi...e Conference in Shanghai and The World Money Show ...
...vista HPV HR: First FDA approved high-risk HPV tes...NA genotyping test approved by the FDA , , BEDFOR... Company) (Nasdaq: HOLX ), a leading women,s hea...Company,s premarket approval (PMA) applications fo...
Other Medicine News:Health News:Extremely affordable health innovations at World Health Care Congress, April 14-16, Washington 2Health News:Extremely affordable health innovations at World Health Care Congress, April 14-16, Washington 3Health News:Optometry Career Conferences Set for Five N.C. Campuses in March 2Health News:UCSF Medical Center receives $125 million gift to build new hospital 2Health News:UCSF Medical Center receives $125 million gift to build new hospital 3Health News:UCSF Medical Center receives $125 million gift to build new hospital 4Health News:Print Media Under Siege - Are Readers Disappearing? 2Health News:China Sky One Medical to Attend Two Conferences in March 2Health News:China Sky One Medical to Attend Two Conferences in March 3Health News:FDA Approves Two Hologic HPV Tests 2Health News:FDA Approves Two Hologic HPV Tests 3Health News:FDA Approves Two Hologic HPV Tests 4
Topcon OM-4 Ophthalmometer
...gital chip technology, the new IMAGEnet 2000 Super...res 3,072 x 2,048 pixels resolution and a 12-bit d...ovides exceptionally sharp and detailed images. It...facilitates instant diagnosis by allowing the inst...
Topcon TLS-FD trial lens set
AIT-15 instrument table
Medicine Products: